RAVULIZUMAB

0 reported adverse events

Drug classes: Complement Inhibitor [EPC]

These side effects are most commonly reported by patients taking RAVULIZUMAB:

# Side effect Count
0 FATIGUE 1819
1 ASTHENIA 925
2 DRUG INEFFECTIVE 775
3 HEADACHE 772
4 DEATH 677
5 OFF LABEL USE 581
6 DYSPNOEA 548
7 MUSCULAR WEAKNESS 532
8 MYASTHENIA GRAVIS 511
9 MALAISE 483
See all common reactions for RAVULIZUMAB

RAVULIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BREAKTHROUGH HAEMOLYSIS 177 0.4436
1 EXTRAVASCULAR HAEMOLYSIS 146 0.3435
2 DISSEMINATED GONOCOCCAL INFECTION 6 0.2222
3 TOTAL COMPLEMENT ACTIVITY DECREASED 8 0.1311
4 GONOCOCCAL INFECTION 9 0.1304
5 MENINGOCOCCAL INFECTION 39 0.1234
6 MENINGOCOCCAL SEPSIS 22 0.1158
7 MENINGITIS MENINGOCOCCAL 19 0.1118
8 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 48 0.1023
9 MYASTHENIA GRAVIS CRISIS 141 0.0951
See all enriched reactions for RAVULIZUMAB